{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T06:27:07Z","timestamp":1781504827312,"version":"3.54.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012446","name":"Akershus Universitetssykehus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012446","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021697","name":"Sykehuset i Vestfold","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021697","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.transci.2021.103257","type":"journal-article","created":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T14:04:15Z","timestamp":1629209055000},"page":"103257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Alloimmunization in transfused patients with constitutional anemias in Norway"],"prefix":"10.1016","volume":"60","author":[{"given":"May Tove","family":"Furuseth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Alme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liv Jorunn","family":"Garvik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marit","family":"Hellebostad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Grete","family":"Bechensteen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c7i\u011fdem Akal\u0131n","family":"Akk\u00f6k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2021.103257_bib0005","series-title":"Handlingsprogram for barn med thalassemi (Norwegian),revised","author":"Hellebostad","year":"2020"},{"issue":"8","key":"10.1016\/j.transci.2021.103257_bib0010","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1111\/trf.14806","article-title":"Red blood cell exchange in patients with sickle cell disease-indications and management: a review and consensus report by the therapeutic apheresis subsection of the AABB","volume":"58","author":"Biller","year":"2018","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.transci.2021.103257_bib0015","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/bjh.12061","article-title":"Challenges of alloimmunization in patients with haemoglobinopathies","volume":"159","author":"Chou","year":"2012","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.transci.2021.103257_bib0020","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ajh.24051","article-title":"Alloimmunization is associated with older age of transfused red blood cells in sickle cell disease","volume":"90","author":"Desai","year":"2015","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.transci.2021.103257_bib0025","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/bjh.13123","article-title":"Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease","volume":"168","author":"Fasano","year":"2015","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.transci.2021.103257_bib0030","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/ajh.24397","article-title":"Early occurrence of red blood cell alloimmunization in patients with sickle cell disease","volume":"91","author":"Sins","year":"2016","journal-title":"Am J Hematol"},{"issue":"April (376(16))","key":"10.1016\/j.transci.2021.103257_bib0035","first-page":"1561","article-title":"Sickle cell disease","volume":"20","author":"Longo","year":"2017","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.transci.2021.103257_bib0040","first-page":"1","article-title":"The prevalence of thalassemia in mainland China: evidence from epidemiological surveys","volume":"04","author":"Lai","year":"2017","journal-title":"Scientific Reports (Nature PubliS.her Group)"},{"key":"10.1016\/j.transci.2021.103257_bib0045","series-title":"Transfusjonstjenesten i Norge","author":"Helsedirektoratet","year":"2017"},{"key":"10.1016\/j.transci.2021.103257_bib0050","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1182\/asheducation-2013.1.447","article-title":"Consequences and management of iron overload in sickle cell disease","volume":"2013","author":"Porter","year":"2013","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"2","key":"10.1016\/j.transci.2021.103257_bib0055","first-page":"214","article-title":"Leucoreduction of blood components: an effective way to increase blood safety?","volume":"14","author":"Bianchi","year":"2016","journal-title":"Blood transfusion."},{"issue":"1","key":"10.1016\/j.transci.2021.103257_bib0060","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-2141.2005.05408.x","article-title":"Alloimmunization to red blood cell antigens after universal leucodepletion. A regional multicentre retrospective study","volume":"129","author":"Schonewille","year":"2005","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.transci.2021.103257_bib0065","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1182\/blood.V96.10.3369","article-title":"Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly asian descent","volume":"96","author":"Singer","year":"2000","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.transci.2021.103257_bib0070","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1365-3148.2006.00656.x","article-title":"Alloimmunization among patients with transfusion-dependent thalassemia in Taiwan","volume":"16","author":"Wang","year":"2006","journal-title":"Transfus Med"},{"issue":"3","key":"10.1016\/j.transci.2021.103257_bib0075","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1179\/102453309X12583347114013","article-title":"Alloimmunization and red cell autoimmunization in multitransfused thalassemics of Indian origin","volume":"15","author":"Pahuja","year":"2010","journal-title":"Hematology"},{"issue":"1-2","key":"10.1016\/j.transci.2021.103257_bib0080","first-page":"95","article-title":"Alloimmunization to red cell antigens in thalassemia: comparative study of usual versus better-match transfusion programmes","volume":"52","author":"Michail-Merianou","year":"1987","journal-title":"Vox Sang"},{"issue":"2","key":"10.1016\/j.transci.2021.103257_bib0085","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1046\/j.1537-2995.1985.25285169198.x","article-title":"Red cell alloantibodies in thalassemia major","volume":"25","author":"Sirchia","year":"1985","journal-title":"Transfusion"},{"issue":"7","key":"10.1016\/j.transci.2021.103257_bib0090","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/00007890-199704150-00010","article-title":"Prospective evaluation of pretransplant blood transfusions in cadaver kidney recipients","volume":"63","author":"Opelz","year":"1997","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.transci.2021.103257_bib0095","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1537-2995.2008.01980.x","article-title":"Alloimmune response after additional red blood cell antigen challenge in immunized hematooncology patients","volume":"49","author":"Schonewille","year":"2009","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.transci.2021.103257_bib0100","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/tme.12314","article-title":"Alloimmunisation rates of sickle cell disease patients in the United States differ from those in other geographical regions","volume":"26","author":"Zheng","year":"2016","journal-title":"Transfus Med"},{"issue":"3","key":"10.1016\/j.transci.2021.103257_bib0105","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1046\/j.1365-2141.2001.02819.x","article-title":"Red cell antibodies in patients with homozygous sickle cell disease: a comparison of patients in Jamaica and the United Kingdom","volume":"113","author":"Olujohungbe","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2021.103257_bib0110","series-title":"The blood group antigen FactsBook","first-page":"147","author":"Reid","year":"2012"},{"key":"10.1016\/j.transci.2021.103257_bib0115","series-title":"Immunologi og transfusjon: Universitetsforlaget","author":"Fagerhol","year":"1995"},{"issue":"3","key":"10.1016\/j.transci.2021.103257_bib0120","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/voxs.12281","article-title":"Effectiveness of a red cell antigen-matching transfusion protocol in sickle cell disease patients","volume":"11","author":"Dezan","year":"2016","journal-title":"ISBT Sci Ser"},{"issue":"8","key":"10.1016\/j.transci.2021.103257_bib0125","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1111\/j.1537-2995.2010.03045.x","article-title":"Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME)","volume":"51","author":"LaSalle-Williams","year":"2011","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.transci.2021.103257_bib0130","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/trf.13347","article-title":"Incidence of alloantibody formation after ABO-D or extended matched red blood cell transfusions: a randomized trial (MATCH study)","volume":"56","author":"Schonewille","year":"2016","journal-title":"Transfusion"},{"issue":"June (6)","key":"10.1016\/j.transci.2021.103257_bib0135","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1111\/trf.14611","article-title":"Red blood cell specifications for patients with hemoglobinopathies: a systematic review and guideline","volume":"58","author":"Compernolle","year":"2018","journal-title":"Transfusion"},{"issue":"6","key":"10.1016\/j.transci.2021.103257_bib0140","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-3148.2011.01102.x","article-title":"Fresh blood for transfusion in adults with beta thalassaemia","volume":"21","author":"Priddee","year":"2011","journal-title":"Transfus Med"},{"issue":"6","key":"10.1016\/j.transci.2021.103257_bib0145","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/MOH.0000000000000540","article-title":"Mechanisms of alloimmunization in sickle cell disease","volume":"26","author":"Hudson","year":"2019","journal-title":"Curr Opin Hematol"},{"issue":"11","key":"10.1016\/j.transci.2021.103257_bib0150","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1111\/trf.12156","article-title":"Effect of storage of red blood cells on alloimmunization","volume":"53","author":"Zalpuri","year":"2013","journal-title":"Transfusion"},{"issue":"6","key":"10.1016\/j.transci.2021.103257_bib0155","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1159\/000369109","article-title":"The Influence of Clinical and Biological Factors on Transfusion-Associated Non-ABO Antigen Alloimmunization: Responders, Hyper-Responders, and Non-Responders","volume":"41","author":"Gehrie","year":"2014","journal-title":"Transfus Med Hemotherapy"},{"issue":"12","key":"10.1016\/j.transci.2021.103257_bib0160","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/ajh.22167","article-title":"Immune regulation in chronically transfused allo-antibody responder and nonresponder patients with sickle cell disease and beta-thalassemia major","volume":"86","author":"Bao","year":"2011","journal-title":"Am J Hematol"},{"issue":"8","key":"10.1016\/j.transci.2021.103257_bib0165","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1111\/trf.12624","article-title":"HLA-DRB1 associations in individuals with single and multiple clinically relevant red blood cell antibodies","volume":"54","author":"Schonewille","year":"2014","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.transci.2021.103257_bib0170","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/trf.13920","article-title":"Red blood cell alloimmunization in patients with sickle cell disease: correlation with HLA and cytokine gene polymorphisms","volume":"57","author":"Sippert","year":"2017","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.transci.2021.103257_bib0175","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/vox.12478","article-title":"Association of HLA\u2010DRB1 and HLA\u2010DQB1 with red\u2010blood\u2010cell alloimmunization in the Czech population","volume":"112","author":"Maluskova","year":"2017","journal-title":"Vox Sang"},{"issue":"1","key":"10.1016\/j.transci.2021.103257_bib0180","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0377-1237(11)80008-0","article-title":"Red cell alloantibodies in multiple transfused thalassaemia patients","volume":"67","author":"Chaudhari","year":"2011","journal-title":"Med J Armed Forces India"},{"issue":"5","key":"10.1016\/j.transci.2021.103257_bib0185","first-page":"1015","article-title":"Red cell immunization in multiply transfused Malay thalassemic patients","volume":"37","author":"Noor Haslina","year":"2006","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"23","key":"10.1016\/j.transci.2021.103257_bib0190","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V126.23.1139.1139","article-title":"The immunogenicity of red blood cell antigens in relation to antigen exposure","volume":"126","author":"Evers","year":"2015","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.transci.2021.103257_bib0195","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1537-2995.2006.00708.x","article-title":"Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity","volume":"46","author":"Schonewille","year":"2006","journal-title":"Transfusion"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050221002494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050221002494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:51:59Z","timestamp":1761468719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050221002494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1473050221002494"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2021.103257","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alloimmunization in transfused patients with constitutional anemias in Norway","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2021.103257","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103257"}}